Your browser doesn't support javascript.
loading
Potential cost savings by dose down-rounding of monoclonal antibodies in a community cancer center.
Copur, Mehmet S; Gnewuch, Curtis; Schriner, Megan; Tharnish, Mark; Gonen, Mithat; McDonald, Monica; Kezeor, Jami; Ramaekers, Ryan C; Gauchan, Dron; Clark, Douglas; Greenwalt, Lois; Mickey, Mary; Norvell, Max.
Afiliação
  • Copur MS; 1 CHI-Health St Francis Cancer Treatment Center, Grand Island, NE, USA.
  • Gnewuch C; 2 University of Nebraska Medical Center, Omaha, NE, USA.
  • Schriner M; 1 CHI-Health St Francis Cancer Treatment Center, Grand Island, NE, USA.
  • Tharnish M; 1 CHI-Health St Francis Cancer Treatment Center, Grand Island, NE, USA.
  • Gonen M; 3 Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • McDonald M; 1 CHI-Health St Francis Cancer Treatment Center, Grand Island, NE, USA.
  • Kezeor J; 1 CHI-Health St Francis Cancer Treatment Center, Grand Island, NE, USA.
  • Ramaekers RC; 1 CHI-Health St Francis Cancer Treatment Center, Grand Island, NE, USA.
  • Gauchan D; 1 CHI-Health St Francis Cancer Treatment Center, Grand Island, NE, USA.
  • Clark D; 1 CHI-Health St Francis Cancer Treatment Center, Grand Island, NE, USA.
  • Greenwalt L; 1 CHI-Health St Francis Cancer Treatment Center, Grand Island, NE, USA.
  • Mickey M; 1 CHI-Health St Francis Cancer Treatment Center, Grand Island, NE, USA.
  • Norvell M; 1 CHI-Health St Francis Cancer Treatment Center, Grand Island, NE, USA.
J Oncol Pharm Pract ; 24(2): 116-120, 2018 Mar.
Article em En | MEDLINE | ID: mdl-29284380
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Redução de Custos / Antineoplásicos Imunológicos / Anticorpos Monoclonais / Neoplasias Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Redução de Custos / Antineoplásicos Imunológicos / Anticorpos Monoclonais / Neoplasias Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article